Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 13 completed trials

    Completion Rate
    100%(13/13)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 3
    13
    100%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    13

    Late Stage

    Phase Distribution13 total trials
    Phase 3Large-scale testing
    13(100.0%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    100.0%

    13 of 13 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    13

    all time

    Status Distribution
    Completed(13)

    Detailed Status

    Completed13

    Development Timeline

    Analytics

    Development Status

    Total Trials
    13
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 3

    Trials by Phase

    Phase 313 (100.0%)

    Trials by Status

    completed13100%

    Recent Activity

    0 active trials
    Showing 5 of 13
    completedphase_3

    Dermacyd in Odor Reducing.

    NCT01158365
    completedphase_3

    Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze

    NCT00664391
    completedphase_3

    Dermacyd Delicata Breeze - Photo Evaluation

    NCT00668486
    completedphase_3

    Dermatological Evaluation of Topic Compatibility - Dermacyd Breeze

    NCT00668577
    completedphase_3

    Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR

    NCT00663390
    View all 13 trials

    Clinical Trials (13)

    Showing 13 of 13 trials
    NCT01158365Phase 3

    Dermacyd in Odor Reducing.

    Completed
    NCT00664391Phase 3

    Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze

    Completed
    NCT00668486Phase 3

    Dermacyd Delicata Breeze - Photo Evaluation

    Completed
    NCT00668577Phase 3

    Dermatological Evaluation of Topic Compatibility - Dermacyd Breeze

    Completed
    NCT00663390Phase 3

    Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR

    Completed
    NCT00668226Phase 3

    Dermacyd Delicata Pocket BR - Photo Evaluation

    Completed
    NCT00668460Phase 3

    Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BR

    Completed
    NCT00668629Phase 3

    Dermacyd Tina Gel Sweet Flower - Photo Evaluation

    Completed
    NCT00668668Phase 3

    Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Sweet Flower

    Completed
    NCT00668889Phase 3

    Dermacyd Tina Gel Tangerina Mix - Photo Evaluation

    Completed
    NCT00669058Phase 3

    Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Tangerina Mix

    Completed
    NCT00663273Phase 3

    Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

    Completed
    NCT00663325Phase 3

    Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

    Completed

    All 13 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    13